Biohaven

Biohaven LT Debt/Equity

The Long-Term Debt to Equity Ratio of Biohaven (BHVN) as of Nov 16, 2026 is 4.59. In the previous year, Long-Term Debt to Equity Ratio was -0.85 — a change of -641.26% (higher).

LT Debt/Equity

4.59

YoY

-641.26%

Last updated:

Long-Term Debt to Equity Ratio of Biohaven is 2025 4.59 . Long-Term Debt to Equity Ratio of Biohaven was 2024 -0.85 . It decreases by -641.26% higher compared to the previous year.

The Biohaven LT Debt/Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

LT Debt/Equity
Date
LT Debt/Equity
Jan 1, 2016
1.18 USD
Jan 1, 2017
0.00 USD
Jan 1, 2018
0.78 USD
Jan 1, 2019
-33.37 USD
Jan 1, 2020
-0.69 USD
Jan 1, 2021
-0.85 USD
Jan 1, 2025
4.59 USD
The Biohaven LT Debt/Equity history
YEARLT Debt/EquityYoY
4.59-641.26%
-0.85+23.72%
-0.69-97.95%
-33.37-4,385.89%
0.78—
0.00-100.00%
1.18—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Biohaven Stock analysis

What does Biohaven do? Biohaven Pharmaceutical Holding Co. Ltd. generates revenue through the research and development of late-stage product candidates targeting neurological diseases and rare disorders. The company utilizes its glutamate platform to advance clinical-stage compounds for various indications, including trigriluzole for obsessive-compulsive disorder, spinocerebellar ataxia, and Alzheimer's disease. Additionally, the firm develops BHV-0223 for amyotrophic lateral sclerosis and BHV-5000 for conditions such as Rett syndrome, neuropathic pain, and treatment-resistant depression. The business model focuses on identifying and developing clinical-stage compounds that target orphan neurologic indications and other neurological pathways, with the company currently employing 825 full-time employees in New Haven, Connecticut. Biohaven is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Biohaven stock

Long-Term Debt to Equity Ratio of Biohaven is 4.59 in 2025.

Long-Term Debt to Equity Ratio of Biohaven changed from -0.85 to 4.59, representing a -641.26% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Long-Term Debt to Equity Ratio Biohaven since 2006 – with annual values, charts, and detailed analysis.

The LT Debt/Equity ratio measures long-term financial leverage. It shows how much permanent debt capital is used relative to equity financing.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Long-Term Debt to Equity Ratio's Biohaven with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Biohaven

All Key Metrics — Biohaven